APA (7th ed.) Citation

Smith, K. J., Minns, D., McHugh, B. J., Holloway, R. K., O'Connor, R., Williams, A., . . . Gwyer Findlay, E. (2022). The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation. PLoS Biology, 20(8), 1. https://doi.org/10.1371/journal.pbio.3001554

Chicago Style (17th ed.) Citation

Smith, Katie J., et al. "The Antimicrobial Peptide Cathelicidin Drives Development of Experimental Autoimmune Encephalomyelitis in Mice by Affecting Th17 Differentiation." PLoS Biology 20, no. 8 (2022): 1. https://doi.org/10.1371/journal.pbio.3001554.

MLA (9th ed.) Citation

Smith, Katie J., et al. "The Antimicrobial Peptide Cathelicidin Drives Development of Experimental Autoimmune Encephalomyelitis in Mice by Affecting Th17 Differentiation." PLoS Biology, vol. 20, no. 8, 2022, p. 1, https://doi.org/10.1371/journal.pbio.3001554.